An efficient convergent synthesis of adenosine-5′-N-alkyluronamides
- 1 February 2008
- journal article
- Published by Elsevier in Tetrahedron
- Vol. 64 (8) , 1772-1777
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Highlights on the Development of A2A Adenosine Receptor Agonists and AntagonistsChemMedChem, 2007
- Cl-IB-MECA [2-Chloro-N6-(3-iodobenzyl)adenosine-5′-N-methylcarboxamide] Reduces Ischemia/Reperfusion Injury in Mice by Activating the A Adenosine ReceptorThe Journal of Pharmacology and Experimental Therapeutics, 2006
- Adenosine receptors as therapeutic targetsNature Reviews Drug Discovery, 2006
- Selective deacetylation using iodine–methanol reagent in fully acetylated nucleosidesTetrahedron Letters, 2005
- A convenient preparation of 1,2,3-tri-O-acetyl-β-d-ribofuranose by enzymatic regioselective 5-O-deacetylation of the peracetylated ribofuranoseCarbohydrate Research, 2004
- Regio-selective deprotection of peracetylated sugars via lipase hydrolysisTetrahedron, 2003
- Adenosine receptor agonistsExpert Opinion on Therapeutic Patents, 2002
- Design, Synthesis, and Evaluation of Novel A2A Adenosine Receptor AgonistsJournal of Medicinal Chemistry, 2001
- Radiolabeling and efficient synthesis of tritiated 2-chloro-N6-(3-iodobenzyl)adenosine-5′-N-methyluron-amide, a potent, selective A3 adenosine receptor agonistJournal of Labelled Compounds and Radiopharmaceuticals, 1996
- 2-Substitution of N6-Benzyladenosine-5'-uronamides Enhances Selectivity for A3 Adenosine ReceptorsJournal of Medicinal Chemistry, 1994